Thermodynamic instability of human λ6 light chains:: Correlation with fibrillogenicity

被引:163
作者
Wall, J
Schell, M
Murphy, C
Hrncic, R
Stevens, FJ
Solomon, A
机构
[1] Univ Tennessee, Grad Sch Med, Human Immunol & Canc Program, Knoxville, TN 37920 USA
[2] Argonne Natl Lab, Ctr Mechanist Biol & Biotechnol, Argonne, IL 60439 USA
关键词
D O I
10.1021/bi991131j
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Certain types of human light chains have the propensity to deposit pathologically as amyloid fibrils as evidenced by the preferential association of monoclonal lambda 6 proteins with AL amyloidosis. However, the molecular features that render such proteins amyloidogenic have not been elucidated. Based upon the demonstrated relationship between the thermodynamic stability of light chains and their propensity to aggregate in vitro, we have initiated studies where the thermodynamic properties and fibrillogenic potential of two recombinant (r) V(lambda)6 molecules were compared. The first protein was generated from cDNA cloned from marrow-derived plasma cells from a patient (Wil) who had AL amyloidosis and renal amyloid deposits; the second was from a patient (Jto) with multiple myeloma in whom the lambda 6 protein was deposited not as amyloid but in the form of renal tubular casts. The thermodynamic stabilities of rV(lambda)6Wil and -Jto were determined from chaotropic and thermal denaturation studies. Based upon the Delta G(H2O), Delta H, Delta G(25) (degrees C), T-m, and C-m values, the rV(lambda)6Wil was less stable than its nonamyloidogenic counterpart, rV(lambda)6Jto. Measurement of fibril formation using a novel in vitro fibril forming assay demonstrated that although both rV(lambda)6 proteins formed fibrils in vitro, Wil had a shorter lag time and exhibited faster kinetics under physiologic conditions. Comparative amino acid sequence analyses of these two components and other lambda 6 amyloid-associated light chains revealed that the Jto protein had certain primary structural features that we posit contributed to its increased stability and thus rendered this protein nonamyloidogenic. Our studies provide the first evidence that stabilizing interactions within the V-L domain can influence the kinetics of light chain fibrillogenicity.
引用
收藏
页码:14101 / 14108
页数:8
相关论文
共 31 条
[1]   VARIABLE-REGION SUBGROUP DISTRIBUTION AMONG LAMBDA-TYPE IMMUNOGLOBULINS IN NORMAL HUMAN SERUM [J].
ABE, M ;
OZAKI, S ;
WOLFENBARGER, D ;
DEBRAMHART, M ;
WEISS, DT ;
SOLOMON, A .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1994, 8 (01) :4-9
[2]   Structural and functional characterization of three human immunoglobulin kappa light chains with different pathological implications [J].
Bellotti, V ;
Stoppini, M ;
Mangione, PP ;
Fornasieri, A ;
Min, L ;
Merlini, G ;
Ferri, G .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1996, 1317 (03) :161-167
[3]   KINETICS OF NUCLEATION-CONTROLLED POLYMERIZATION - A PERTURBATION TREATMENT FOR USE WITH A SECONDARY PATHWAY [J].
BISHOP, MF ;
FERRONE, FA .
BIOPHYSICAL JOURNAL, 1984, 46 (05) :631-644
[4]   Mutational effects on inclusion body formation in the periplasmic expression of the immunoglobulin V-L domain REI [J].
Chan, W ;
Helms, LR ;
Brooks, I ;
Lee, G ;
Ngola, S ;
McNulty, D ;
Maleeff, B ;
Hensley, P ;
Wetzel, R .
FOLDING & DESIGN, 1996, 1 (02) :77-89
[5]  
CHANG LY, 1994, MOL IMMUNOL, V31, P531
[6]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[7]  
Eftink MR, 1995, METHOD ENZYMOL, V259, P487
[8]   Medical progress - The systemic amyloidoses [J].
Falk, RH ;
Comenzo, RL ;
Skinner, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (13) :898-909
[9]  
GHISO J, 1986, J IMMUNOL, V136, P716
[10]   Models of amyloid seeding in Alzheimier's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins [J].
Harper, JD ;
Lansbury, PT .
ANNUAL REVIEW OF BIOCHEMISTRY, 1997, 66 :385-407